- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04579614
Performance Feedback in Health Care
The Southeast Permanente Medical Group (TSPMG) at Kaiser Permanente Georgia provides performance feedback to its providers. The performance feedback designs can vary and change over time in terms of targets, summary statistics, included measures, and frequency of delivery. The TSPMG health services research group seek to compare different performance feedback designs to identify which are most effective at contributing to performance improvement.
The research team will randomly assign providers into different performance feedback conditions, as specified in the protocol. Providers will receive performance feedback through the standard mechanism in which it is conveyed by their supervisor.
The objective is to investigate how to design performance feedback for providers to best motivate and support them in improving performance along with existing strategic priorities for care delivery.
The reserach team will test alternative designs of performance feedback that vary on the following dimension:
1) targets for comparison of one's own performance
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
The Southeast Permanente Medical Group (TSPMG) provides performance feedback to its providers. The performance feedback designs can vary and change over time in terms of targets, summary statistics, included measures, and frequency of delivery. The TSPMG health services research team will seek to compare different performance feedback designs to identify which are most effective at contributing to performance improvement. .
The research team will randomly assign providers into different performance feedback conditions, as specified in the protocol. Providers will receive performance feedback through the standard mechanism in which it is conveyed by their supervisor.
The objective is to investigate how to design performance feedback for providers to best motivate and support them in improving performance along with existing strategic priorities for care delivery.
The research team will test alternative designs of performance feedback that vary on the following dimension:
1) targets for comparison of one's own performance
The research team will provide feedback on performance by measures that the organization already tracks internally and uses for performance improvement. These include a provider's utilization of opportunities to provide flu vaccinations.
The study will randomly assign different designs of feedback to providers. In order to understand which designs of feedback have the best effects on performance, the research team will test the following hypotheses:
Displaying the next-highest quartile will motivate improvement more than display of all quartiles.
Theory: The next-highest quartile will serve as an injunctive norm, or suggested target, to repeatedly lift an individual's performance to the suggested level.
The positive effect of displaying the next-highest quartile, relative to displaying all quartiles, will be most pronounced for initially low performers.
Theory: The next highest quartile averts upward social comparison to a much higher level of peer performance, which can be discouraging and so negatively affect performance
The positive effect of displaying the next-highest quartile, relative to displaying all quartiles, will diminish over time.
Theory: Individuals may become worn out as they see a target ratchet higher when their performance improves.
- Displaying team relative performance along with individual relative performance will be more effective than displaying either type of information alone.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30305
- Kaiser Permanente Georgia Regional Offices
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
A healthcare provider practicing at The Southeast Permanente Medical Group in a specialty for which the performance measure being studied is relevant.
Health care providers include:
Physicians, Nurse Practitioner, Certified Nurse Midwife, Psych Nurse Specialist, Optometrist, Podiatrist, and Physician Assistant
Exclusion Criteria:
Non-Physicians: Registered Nurses excluding nurse practitioners
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Organizational Target
Providers are shown the flu success performance rate of their team (a "pod," or group of providers who practice together), in comparison to their own, and with the organizational target.
These updates and targets are sent bi-weekly.
|
A given provider will be involved in the study for a maximum of 6 months. This will involve, at the most frequent, the delivery of weekly performance feedback. The performance feedback will be delivered using standard approaches already in place in the organization and there will not be a period of seeking out participants for enrollment. Providers will receive performance feedback bi-weekly for the duration of the study period. |
|
Eksperimentel: Achievable Target
Providers are shown the flu success performance rate of their team (a "pod," or group of providers who practice together), in comparison to their own.
They will receive a static and achievable target based on their previous year's flu vaccination success rate.
|
A given provider will be involved in the study for a maximum of 6 months. This will involve, at the most frequent, the delivery of weekly performance feedback. The performance feedback will be delivered using standard approaches already in place in the organization and there will not be a period of seeking out participants for enrollment. Providers will receive performance feedback bi-weekly for the duration of the study period. |
|
Eksperimentel: Variable
Providers are shown the flu success performance rate of their team (a "pod," or group of providers who practice together), in comparison to their own.
They will receive a variable target that will fluctuate bi-weekly, based on their previous bi-weekly flu vaccination success rate.
|
A given provider will be involved in the study for a maximum of 6 months. This will involve, at the most frequent, the delivery of weekly performance feedback. The performance feedback will be delivered using standard approaches already in place in the organization and there will not be a period of seeking out participants for enrollment. Providers will receive performance feedback bi-weekly for the duration of the study period. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Flu Vaccination Administered During Encounter
Tidsramme: 10 Weeks
|
Whether or not the providers succeeded in administering flu vaccination during flu vaccination opportunity
|
10 Weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 1535959-1
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Influenza
-
Gamaleya Research Institute of Epidemiology and...AfsluttetInfluenza A | Influenza A-virusinfektion | Influenza epidemi | Influenza H5N1Den Russiske Føderation
-
NPO PetrovaxAfsluttetVaccine reaktion | Influenza | Influenza, menneske | Influenza A | Akut luftvejsinfektion | Influenza type B | Influenza | Influenza A H3N2 | Influenza A H1N1 | Influenza, menneske | Influenza epidemiDen Russiske Føderation
-
Vanderbilt University Medical CenterHuman Vaccines ProjectAfsluttetVaccine reaktion | Influenza | Influenza, menneske | Influenza A | Influenza type B | Influenza A H3N2 | Influenza A H1N1Forenede Stater
-
Institute of Medical Biology, Chinese Academy of...Guangxi Zhuang Autonomous Region Center for Disease Prevention and ControlAktiv, ikke rekrutterendeInfluenza, menneske | Influenza type B | Influenza virale infektioner | Influenza aKina
-
ModernaTX, Inc.RekrutteringInfluenzaForenede Stater, Det Forenede Kongerige
-
Institute of Medical Biology, Chinese Academy of...Guangxi Zhuang Autonomous Region Center for Disease Prevention and ControlIkke rekrutterer endnuInfluenza, menneske | Influenza virale infektioner | Influenza B | Influenza, menneskelig forebyggelse | Influenza aKina
-
Dre Pauline VetterUniversity of Zurich; University Hospital, Geneva; Swiss National Science... og andre samarbejdspartnereRekrutteringInfluenza sygdom; InfluenzaSchweiz
-
SeqirusNovartis VaccinesAfsluttetInfluenza | Influenza, menneske | Influenza A-virus, H5N1-undertype | Influenza, menneske | Influenza, fugleAustralien, Tyskland, Italien
-
Novartis VaccinesAfsluttetInfluenza | Sæsonbestemt influenza | Menneskelig influenza | Influenza på grund af uspecificeret influenzavirusBelgien
-
Novartis VaccinesNovartis Vaccines and Diagnostics (formerly Chiron Vaccines)AfsluttetInfluenza sygdom; InfluenzaForenede Stater